GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Endologix Inc (ELGX) [hlAlert]

Rating:
Outperform
ELGX
down 7.29 %

Endologix Inc (ELGX) rated Outperform with price target $17 by RBC Capital Mkts

Posted on: Monday,  Oct 19, 2015  8:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Endologix Inc (NASDAQ: ELGX) on 10/19/2015, when the stock price was $13.98.
Since then, Endologix Inc has lost 7.30% as of 01/14/2016's recent price of $12.96.
If you would have followed this RBC Capital Mkts's recommendation on ELGX, you would have lost 7.29% of your investment in 87 days.

Endologix, Inc., incorporated in March 1992, develops, manufactures, markets and sells treatments for aortic disorders. The Company?s product, the Powerlink System is a minimally invasive device for the treatment of abdominal aortic aneurysm (AAA). AAA is a weakening of the wall of the aorta, an artery of the body. Once AAA develops, it continues to enlarge and if left untreated becomes susceptible to rupture. The Powerlink System is a catheter and endoluminal stent graft (ELG) system. The device consists of a self-expanding cobalt chromium alloy stent cage covered by expanded polytetrafluoroethylene (ePTFE), a surgical graft material. Sale of its Powerlink System in the United States, Europe, Japan and Latin America are the primary sources of the Company?s revenues.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/19/2015 8:25 AM Buy
None
13.98 17.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy